跳到正文
Endpoints News· Ayisha Sharma·· 2 小时前AI 评分30

Sanofi CEO:Dupixent 专利悬崖临近,暂无“重大”重组计划

Sanofi has no plans for a 'major' overhaul as Dupixent's patent cliff looms

AI 导读

Sanofi 表示在 Dupixent 专利悬崖临近之际不计划进行“重大”重组。此番表态距 Belén Garijo 接任 CEO 已六个月,公司于周五作出上述说明。

正文 · 原文

It’s been six months since Belén Gar­i­jo took over as the CEO for Sanofi, and the French drug­mak­er said Fri­day it is not plan­ning “ma­jor” …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News · endpoints.news

AI 摘要声明:站内标题、摘要与推荐理由由模型基于公开来源生成,属机器生成内容,非原文;本页内容仅供医药行业信息参考,不构成医疗建议、诊断或用药依据。